Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
1.310
0.00 (-0.01%)
Jan 23, 2025, 12:12 PM EST - Market open
Vor Biopharma Employees
Vor Biopharma had 168 employees as of December 31, 2023. The number of employees increased by 35 or 26.32% compared to the previous year.
Employees
168
Change (1Y)
35
Growth (1Y)
26.32%
Revenue / Employee
n/a
Profits / Employee
-$669,423
Market Cap
163.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 168 | 35 | 26.32% |
| Dec 31, 2022 | 133 | -2 | -1.48% |
| Dec 31, 2021 | 135 | 47 | 53.41% |
| Dec 31, 2020 | 88 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
VOR News
- 15 days ago - Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors - GlobeNewsWire
- 27 days ago - Vor Bio Announces $55.6 Million Private Placement - GlobeNewsWire
- 6 weeks ago - Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design - GlobeNewsWire
- 4 months ago - Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer - GlobeNewsWire
- 4 months ago - What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - Benzinga
- 4 months ago - New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies - GlobeNewsWire
- 5 months ago - Vor Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire